Allurion Technologies, Inc. is a pioneering healthcare company headquartered in Natick, Massachusetts, that is revolutionizing the treatment of obesity with its innovative weight loss platform. Its flagship product, the Elipse Balloon, is a non-surgical solution that enables patients to achieve significant, sustainable weight loss while fitting seamlessly into their lifestyles. With a strong focus on clinical excellence and user experience, Allurion is poised to capitalize on the growing global demand for effective obesity treatments, positioning itself as a crucial player in the dynamic medtech sector. As the company continues to advance its technology and expand its market presence, it is well-equipped to drive substantial growth and contribute to improved health outcomes worldwide. Show more

Location: 11 HURON DRIVE, NATICK, MA, UNITED STATES, 01760, Natick, MA, 01760, USA | Website: https://www.allurion.com | Industry: MEDICAL DEVICES | Sector: HEALTHCARE


Market Cap

18.68M

52 Wk Range

$1.02 - $7.12

Previous Close

$1.52

Open

$1.54

Volume

29,111

Day Range

$1.47 - $1.54

Enterprise Value

45.92M

Cash

6.136M

Avg Qtr Burn

-6.544M

Insider Ownership

6.37%

Institutional Own.

54.53%

Qtr Updated

09/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

We track quarterly 13F filings for some of the largest biotech hedge funds here.